Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of nanobody and application of anti-B cell growth stimulating factor

A technology of growth stimulation and nano-antibody, applied in the direction of anti-receptor/cell surface antigen/cell surface determinant immunoglobulin, antibody, biochemical equipment and method, etc. Effects on B cell proliferation or survival

Active Publication Date: 2018-03-27
SHENZHEN PREGENE BIOPHARMA CO LTD
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] No nanobodies against BAFF have been reported so far

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of nanobody and application of anti-B cell growth stimulating factor
  • A kind of nanobody and application of anti-B cell growth stimulating factor
  • A kind of nanobody and application of anti-B cell growth stimulating factor

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0053] Example 1: Expression of BAFF extracellular protein

[0054] 1. Extraction of sBAFF gene: extract normal human venous blood, and extract peripheral blood mononuclear cells (PBMC) according to conventional methods. The RNA extraction was carried out in accordance with Invitorgen's instructions. Take 3ug RNA reverse transcription to prepare cDNA template, and use it as template to amplify BAFF gene.

[0055] The primer sequence is:

[0056] 5’CGGGAATTCCTGGTGCCACGCGGTGCCGTCAGGGTCCAGAAG3’ (SEQ ID No.3)

[0057] 5’CCCAAGCTTTCACAGCAGTTTCAATGC3’ (SEQ ID No. 4)

[0058] PCR reaction conditions:

[0059]

[0060] 2. Construction of expression vector: PCR amplified products are separated and recovered by agarose gel electrophoresis, digested with EcoRI (BioLab) and HindIII (BioLab), and then press 3 with the vector pET-30a (Sigma) treated with the same enzyme. :1 end ratio for sticky end connection. Connection product according to CaCl 2 The transformation method was used to transform c...

Embodiment 2

[0067] Example 2: Construction of anti-BAFF specific Nanobody library

[0068] 1. Immunize the alpaca and analyze the production of nano antibodies by enzyme immunoassay.

[0069] A total of 1.5 mg of antigen was injected subcutaneously on the back of the alpaca's neck and Freund’s adjuvant was added for 4 immunizations. The absorption of the injected mass was followed up to confirm the correct immunization. Serum antibody titer was determined one month after the first immunization ( figure 2 ); After immunization, the interval between each immunization is halved, and the titer is determined. The protein G column and affinity chromatography were used to separate the serum one week after the fourth immunization, and the ELISA method was used to detect the production of heavy chain antibodies and antibody titer. After the fourth immunization, the titer of alpaca immune serum can reach 1: 10000. ( image 3 ).

[0070] 2. Isolation of alpaca peripheral blood lymphocytes

[0071] Isola...

Embodiment 3

[0100] Example 3: Obtaining anti-BAFF Nanobodies

[0101] 1. Screening of anti-BAFF specific Nanobodies

[0102] Biotinylated BAFF and streptavidin magnetic beads were used to screen antibodies from the phage library to obtain anti-BAFF Nanobodies. The biotin-labeled BAFF antigen and the phage antibody library were mixed in proportion, and reacted overnight at 4°C. Add the antigen-phage antibody complex to the EP tube containing streptavidin magnetic beads, and roll for 0.5h to make the magnetic beads fully bind to the biotin-labeled antigen-phage antibody complex. After rinsing each with PBST (0.05% T20) and PBS 10 times, the phages were eluted with TEA, and they were allowed to stand at room temperature for 10 minutes. Add TEA in 1M Tris-HCl and store on ice. The phage was infected with TG1 in the semi-log phase. Diluted the appropriate amount of bacterial solution and spread it on an AMP / LB plate, incubated at 32°C, and measured the titer of the eluate. The supernatant was c...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
purityaaaaaaaaaa
affinityaaaaaaaaaa
Login to View More

Abstract

The invention discloses an anti-B cell growth stimulating factor nanobody and its use, and belongs to the field of biotechnology. A nanobody against B cell growth stimulating factor, the amino acid sequence of which is shown in SEQ ID NO.1 in the sequence listing. The advantage of the present invention is that: the present invention screens a plurality of nanobodies with high activity and potential neutralization ability, and finally obtains the anti-BAFF nanobody G3. The nanobody can specifically bind the human BAFF antigen, regulate the biological activity related to the BAFF antigen and its ligand, effectively inhibit the binding of the BAFF antigen to its receptor and generate corresponding signal cascade effects. The anti-BAFF nanobody can block the binding of BAFF and its three related receptors, and significantly inhibit the proliferation or survival of B cells. The nanobody can be used to detect and / or treat a variety of diseases related to abnormal expression of BAFF.

Description

Technical field [0001] The invention relates to a nano antibody against B cell growth stimulating factor and its use, belonging to the field of biotechnology. Background technique [0002] Lymphoma is a malignant tumor that originates in lymph nodes or lymph tissues. It has a large number of lymphocytes and (or) tissue cells. It accounts for the eighth most common malignant tumor in my country. It has a trend of younger generation. The incidence rate in recent years has ranged from 2-4 100,000 rises to 6.91 per 100,000, and increases at a rate of 5% per year. There are about 50,000 new patients and more than 20,000 deaths each year. It is generally believed that Hodgkin’s lymphoma is mainly derived from B cells, and most non-Hodgkin’s lymphomas are also derived from B cells. Therefore, treatment of lymphoma by removing B cells has become a new treatment option. [0003] Clinical studies have found that malignant B cells such as lymphoma can synthesize and secrete a protein called B...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K16/28C12N15/13C12N15/63G01N33/68A61K39/395A61P35/00A61P35/02A61P37/02A61P29/00
Inventor 张伟京李胜华孙剑武文任光达
Owner SHENZHEN PREGENE BIOPHARMA CO LTD